Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial-Reference-Cited by-同舟云学术

Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial

Published:2020-04 Issue: Volume:145 Page:71-80
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Murthy Vedang^ORCID,Maitre Priyamvada,Bhatia Jatin^ORCID,Kannan Sadhana,Krishnatry Rahul^ORCID,Prakash Gagan,Bakshi Ganesh,Pal Mahendra,Menon Santosh,Mahantshetty Umesh^ORCID

Funder

Terry Fox Foundation

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference16 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2018

2. Prostate radiotherapy in india: evolution, practice and challenges in the 21st century;Murthy;Clin Oncol,2019

3. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial;Roach;Lancet Oncol,2018

4. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Update of the long-term survival results of the GETUG-01 randomized study;Pommier;Int J Radiat Oncol Biol Phys,2016

5. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial;Bruner;Cancer,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study;Clinical and Translational Radiation Oncology;2024-09

3. Tolérance à court et moyen terme d’une radiothérapie prostatique hypofractionnée selon la technique du boost intégré;Cancer/Radiothérapie;2024-08

4. Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines;Clinical Oncology;2024-07

5. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06